Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness
Sebastian Vollmer,Bilal A Mateen,Gergo Bohner,Franz J Király,Rayid Ghani,Pall Jonsson,Sarah Cumbers,Adrian Jonas,Katherine S L McAllister,Puja Myles,David Granger,Mark Birse,Richard Branson,Karel G M Moons,Gary S Collins,John P A Ioannidis,Chris Holmes,Harry Hemingway,David Grainger
DOI: https://doi.org/10.1136/bmj.l6927
2020-03-20
BMJ
Abstract:Machine learning (ML), artificial intelligence (AI), and other modern statistical methods are providing new opportunities to operationalise previously untapped and rapidly growing sources of data for patient benefit. The potential uses include improving diagnostic accuracy,1 more reliably predicting prognosis,2 targeting treatments,3 and increasing the operational efficiency of health systems.4 Examples of potentially disruptive technology with early promise include image based diagnostic applications of ML/AI, which have shown the most early clinical promise (eg, deep learning based algorithms improving accuracy in diagnosing retinal pathology compared with that of specialist physicians5), or natural language processing used as a tool to extract information from structured and unstructured (that is, free) text embedded in electronic health records.2 Although we are only just beginning to understand the wealth of opportunities afforded by these methods, there is growing concern in the academic community that because the products of these methods are not perceived in the same...